Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Sanara MedTech (SMTI) Short-Term Debt issuances (2010 - 2025)

Sanara MedTech posted quarterly Short-Term Debt issuances of -$44433.0 for Q2 2025, down 100.37% on a QoQ basis from $12.1 million in Q1 2025.

Sanara MedTech (SMTI) has 6 years of Short-Term Debt issuances data on file, last reported at -$44433.0 in Q2 2025.

For the quarter ending Q2 2025, Short-Term Debt issuances changed N/A year-over-year to -$44433.0; the trailing twelve-month figure through Dec 2025 stood at $12.0 million (down 21.05% YoY), and the FY2025 full-year result was $12.0 million, down 59.02% from the prior year.
Short-Term Debt issuances for Q2 2025 stood at -$44433.0, down from $12.1 million in the prior quarter.
Across five years, Short-Term Debt issuances topped out at $15.2 million in Q3 2024 and bottomed at -$44433.0 in Q2 2025.
The 3-year median for Short-Term Debt issuances is $6.4 million (2021), against an average of $7.0 million.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Short-Term Debt issuances (Qtr)
1	Intuitive Surgical	156.17 Bn	151.78 Bn	1.83 Bn	-
2	Becton Dickinson	41.51 Bn	40.49 Bn	2.15 Bn	11.00 Mn
3	Resmed	30.43 Bn	28.77 Bn	890.98 Mn	-
4	West Pharmaceutical Services	22.78 Bn	22.26 Bn	296.40 Mn	-
5	Solventum	13.39 Bn	13.39 Bn	1.10 Bn	-
6	Cooper Companies	12.33 Bn	12.20 Bn	695.20 Mn	22.00 Mn
7	Align Technology	11.65 Bn	10.59 Bn	736.59 Mn	-
8	Baxter International	9.81 Bn	7.77 Bn	891.00 Mn	-
9	Aptargroup	7.39 Bn	7.19 Bn	351.91 Mn	7.00 Mn
10	Sanara MedTech	203.69 Mn	190.09 Mn	25.87 Mn	-

Historic Data

Download Data 🔒

Date	Value
Jun 30, 2025	-44,433.00
Jun 30, 2025	-44,433.00
Mar 31, 2025	12.07 Mn
Mar 31, 2025	12.07 Mn
Sep 30, 2024	15.23 Mn
Sep 30, 2024	15.23 Mn
Mar 31, 2021	800,000.00
Mar 31, 2021	800,000.00
Dec 31, 2019	200,000.00
Dec 31, 2019	200,000.00
Jun 30, 2019	500,000.00
Jun 30, 2019	500,000.00
Mar 31, 2019	500,000.00
Mar 31, 2019	500,000.00
Sep 30, 2012	-11,913.00
Sep 30, 2012	-11,913.00
Sep 30, 2010	-4,363.00
Sep 30, 2010	-4,363.00